CGC - Canopy Growth Corporation

NYSE - NYSE Delayed Price. Currency in USD
29.23
-0.14 (-0.48%)
At close: 4:01PM EST

29.08 -0.15 (-0.51%)
After hours: 7:56PM EST

Stock chart is not supported by your current browser
Previous Close29.37
Open29.74
Bid28.75 x 1300
Ask0.00 x 800
Day's Range28.31 - 30.09
52 Week Range16.74 - 59.25
Volume5,925,131
Avg. Volume11,501,071
Market Cap10.107B
Beta (3Y Monthly)2.33
PE Ratio (TTM)N/A
EPS (TTM)-1.79
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • New York state looks to legalize recreational marijuana
    Yahoo Finance Video6 hours ago

    New York state looks to legalize recreational marijuana

    New York Governor Andrew Cuomo prioritized legalizing recreational marijuana use in the state. Yahoo Finance's Julie Hyman, Adam Shapiro, Rick Newman, Liz Young, Director of Market Strategy, BNY Mellon Investment Management and Marijuana Business Daily Founding Editor and Vice President Chris Walsh discuss.

  • Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
    Zacks3 hours ago

    Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

    In the latest trading session, Canopy Growth Corporation (CGC) closed at $29.21, marking a -0.54% move from the previous day.

  • GlobeNewswire6 hours ago

    Canopy Rivers Portfolio Company TerrAscend Gains Traction in New Jersey Medical Cannabis Market

    OTCQX: TRSSF), NETA NJ LLC (“NETA”), has been selected by the State of New Jersey Department of Health to apply for final approval to operate a vertically integrated Alternative Treatment Center (ATC), which would permit it to cultivate, process and sell medical cannabis in the state. The State of New Jersey received a total of 146 applications to cultivate, process and sell medical cannabis.

  • InvestorPlace8 hours ago

    Check Your Risk Tolerance Before Inhaling Aphria Stock

    Although it has risen from recent lows, the pain for Aphria (NYSE:APHA) stock continues. With the credibility of Aphria’s management called into question by short-seller research reports, APHA has now fallen below Cronos (NASDAQ:CRON) in market cap. With APHA trading at a much lower valuation than its peers, the case for a risky contrarian play in Aphria stock only grows stronger.

  • InvestorPlace10 hours ago

    What to Expect From Cronos Stock In the Latest Pot Hype Cycle

    Marijuana stocks like Cronos Group (NASDAQ:CRON) stock have spent 2018 in the hype cycle. The hype cycle is a term common to technology investors. Now, just as things settle down, Altria (NYSE:MO), formerly the U.S. unit of Philip Morris, is paying $1.8 billion to get 45% of Cronos, a medical marijuana company based in Canada.

  • ACCESSWIRE12 hours ago

    4 Marijuana Stocks To Watch On Tuesday 12/18/2018

    CORAL GABLES, FL / ACCESSWIRE / December 18, 2018 / Marijuana stocks have seen a lot of excitement this year. As 2019 gets closer, Premier Health Group (OTC: PHGRF) (CSE: PHGI) , Aurora Cannabis (NYSE: ...

  • ACCESSWIRE13 hours ago

    Today's Research Reports on Trending Tickers: Aurora Cannabis and Canopy Growth

    NEW YORK, NY / ACCESSWIRE / December 18, 2018 / U.S. equities extended losses on Monday as investors await details from the Federal Reserve's final policy meeting of 2018 on Wednesday. The Dow Jones Industrial ...

  • InvestorPlace15 hours ago

    Cronos Stock Should Be a Buy — Just Not Yet

    Cronos executed a potentially transformative deal with tobacco giant Altria (NYSE:MO). Indeed, I’m somewhat surprised by the reaction, in terms of both Cronos stock and pot stocks on the whole. As rumors of a deal flew earlier this month, I wrote that an executed agreement would be transformative for CRON stock, and the industry.

  • ACCESSWIREyesterday

    4 Marijuana Stocks To Watch Before Christmas

    Not only has it caused a stir with US pot stocks but Canadian marijuana stocks are also seeing more activity this week. With marijuana stocks in focus, here are 4 pot stocks to watch this month. Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced earlier this month that as a part of its growth strategy to cover the major verticals associated with primary care, it has signed a binding Letter of Intent to acquire a Vancouver, British Columbia based pharmacy.

  • This Tiny Marijuana Stock Could Be Better Prepared for the Coming Supply Glut Than Canopy Growth and Tilray
    Motley Fool2 days ago

    This Tiny Marijuana Stock Could Be Better Prepared for the Coming Supply Glut Than Canopy Growth and Tilray

    When the going gets tough in the Canadian marijuana market, there could be a surprising winner.

  • Better Buy: Canopy Growth vs. Cronos Group
    Motley Fool3 days ago

    Better Buy: Canopy Growth vs. Cronos Group

    Big deals for both of these marijuana producers have excited investors. But which stock will be the bigger winner down the road?

  • Hemp Is on the Brink of U.S. Legalization: Is Canopy Growth Positioned to Profit?
    Motley Fool3 days ago

    Hemp Is on the Brink of U.S. Legalization: Is Canopy Growth Positioned to Profit?

    Congress passed the Farm Bill this week, which President Trump is expected to sign, opening the floodgates for rapid growth in the hemp-derived CBD product market in the U.S.

  • This Small-Cap Cannabis Stock Is Up Big in a Down Market. Here's Why.
    Motley Fool4 days ago

    This Small-Cap Cannabis Stock Is Up Big in a Down Market. Here's Why.

    Medical Marijuana's stock has started to heat up. Here's why.

  • InvestorPlace4 days ago

    Aurora Stock Needs This One Thing Before It’s a Strong Buy

    Canada’s cannabis leader is currently Aurora Cannabis (NYSE:ACB). This is a well established and rapidly growing cannabis company. Namely, alcoholic beverage giant Constellation Brands (NYSE:STZ) and Marlboro cigarette maker Altria (NYSE:MO) have both made billion dollar investments into Canadian cannabis companies Canopy Growth (NYSE:CGC) and Cronos (NASDAQ:CRON), respectively.